Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Fiserv
FI
|
$723M |
| 2 |
GSK
GSK
|
$660M |
| 3 |
RTX Corp
RTX
|
$628M |
| 4 |
Wells Fargo
WFC
|
$527M |
| 5 |
Cisco
CSCO
|
$370M |
Top Sells
| 1 |
FedEx
FDX
|
$997M |
| 2 |
TE Connectivity
TEL
|
$880M |
| 3 |
Bank of America
BAC
|
$603M |
| 4 |
AstraZeneca
AZN
|
$575M |
| 5 |
Charles Schwab
SCHW
|
$564M |
Sector Composition
| 1 | Financials | 27.05% |
| 2 | Technology | 18.36% |
| 3 | Communication Services | 14.15% |
| 4 | Healthcare | 14.14% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioMarin Pharmaceuticals
BMRN
$11.2B
| $859M | 0.68% | 9,796,924 +2,076,701 | +27% | +$182M |
|
52
Baidu
BIDU
$32.8B
| $808M | 0.64% | 3,738,621 -990,300 | -21% | -$214M |
|
53
APA Corp
APA
$8.31B
| $741M | 0.59% | 52,194,876 -111,370 | -0.2% | -$1.58M |
|
|
54
Fiserv
FI
$75.1B
| $723M | 0.57% | +6,349,031 | New | +$723M |
|
55
Nutrien
NTR
$28B
| $716M | 0.57% | 14,874,614 -147,200 | -1% | -$7.09M |
|
56
Alibaba
BABA
$322B
| $667M | 0.53% | 2,867,800 -92,700 | -3% | -$21.6M |
|
|
QVCGA
57
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $651M | 0.51% | 59,343,040 -1,969,134 | -3% | -$21.6M |
|
58
Medtronic
MDT
$119B
| $639M | 0.5% | 5,451,591 -283,846 | -5% | -$33.2M |
|
59
Alnylam Pharmaceuticals
ALNY
$58.5B
| $603M | 0.48% | 4,639,913 -37,700 | -0.8% | -$4.9M |
|
60
Halliburton
HAL
$19.4B
| $555M | 0.44% | 29,338,672 -2,033,473 | -6% | -$38.4M |
|
61
LyondellBasell Industries
LYB
$18.1B
| $554M | 0.44% | 6,039,403 -359,517 | -6% | -$33M |
|
62
Televisa
TV
$1.49B
| $535M | 0.42% | 64,947,420 -2,610,200 | -4% | -$21.5M |
|
|
GAP
63
The Gap, Inc.
GAP
$8.21B
| $511M | 0.4% | 25,313,027 -1,418,555 | -5% | -$28.6M |
|
64
JD.com
JD
$44.1B
| $487M | 0.39% | 5,545,877 -1,118,300 | -17% | -$98.3M |
|
65
Ovintiv
OVV
$10.8B
| $472M | 0.37% | 32,851,897 -3,410,400 | -9% | -$49M |
|
66
Aegon
AEG
$12.3B
| $464M | 0.37% | 117,432,884 -1,191,633 | -1% | -$4.71M |
|
67
Otis Worldwide
OTIS
$33.9B
| $451M | 0.36% | 6,678,253 -2,139,931 | -24% | -$145M |
|
68
Liberty Global Class C
LBTYK
$4.07B
| $421M | 0.33% | 17,783,768 -1,804,893 | -9% | -$42.7M |
|
69
Credicorp
BAP
$20.4B
| $411M | 0.33% | 2,507,096 +982,872 | +64% | +$161M |
|
70
T-Mobile US
TMUS
$284B
| $365M | 0.29% | 2,705,277 -172,756 | -6% | -$23.3M |
|
71
TC Energy
TRP
$54.1B
| $362M | 0.29% | 8,892,873 +8,574,600 | +2,694% | +$349M |
|
72
Linde
LIN
$224B
| $359M | 0.28% | 1,382,090 -131,300 | -9% | -$34.1M |
|
73
Brighthouse Financial
BHF
$2.7B
| $359M | 0.28% | 9,907,961 -84,961 | -0.9% | -$3.08M |
|
74
Fox Class B
FOX
$24.3B
| $296M | 0.23% | 10,266,448 -12,351 | -0.1% | -$357K |
|
75
Lincoln National
LNC
$8.14B
| $293M | 0.23% | 5,833,207 +21,150 | +0.4% | +$1.06M |
|